Thursday, December 14, 2006 12:15:17 PM
Job Title: Director, Behavioral Pharmacology
Employer: Cortex Pharmaceuticals, Inc.
Location: Irvine, CA
Date: 11-06-2006
Description: Cortex Pharmaceuticals, Inc., an Irvine, California-based neuroscience company focused on novel drug therapies for the treatment of neurological and psychiatric disorders, is currently recruiting for a Director, Behavioral Pharmacology. We are seeking an in vivo pharmacologist (PhD) with a strong background in the area of rodent Central Nervous System (CNS) behavioral models. The successful candidate will initiate and/or direct in vivo behavioral pharmacology studies to support drug discovery programs and progression of development candidates in the areas of cognition and neurodegeneration. These studies will be performed internally as well as through contract research organizations (CRO's). The successful candidate will possess effective leadership skills, work well in a team, be objective-driven, and understand the importance of project timelines. Candidates should have experience of discovery-based projects and understand the essential elements of drug development in the neuroscience area
The successful candidate will:
* Establish appropriate cognition and neurodegeneration in vivo behavioral assays to support drug discovery programs
* Interact closely with medicinal chemists and biologists
* Design, initiate, monitor, and report in vivo behavioral assays to support drug discovery efforts and elucidate the desired/undesired pharmacology
* Provide strategic leadership to discovery programs at Cortex
* Develop and maintain connections to cutting research at major academic and pharmaceutical companies within the company's therapeutic areas
* Ensure effective internal and external scientific communications (e.g., report writing, publications, abstracts)
Knowledge, Skills, and Abilities:
* A Ph.D. in pharmacology, or related field, with greater than 10 years' experience in the pharmaceutical/biotechnology industry in drug discovery research
* Although there will be an emphasis to conduct studies in house, some pharmacological studies may be performed through academic collaborators or CRO's, and therefore the successful candidate must have the ability to initiate, organize, follow through, and communicate with the appropriate individuals
* Requires a high level of initiative and independence. Excellent written and oral communication skills are required. Familiarity with statistics, personal computer and commonly used applications, e.g., Microsoft Excel, Word, Powerpoint are expected
* Work hours may include meetings scheduled outside of normal working hours. Demands during peak times may require work hours outside of normal working hours. A limited amount of domestic and international travel is expected
Recent RSPI News
- Form 8-K - Current report • Edgar (US Regulatory) • 09/06/2024 12:45:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/02/2024 12:30:23 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/08/2024 08:01:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/29/2024 01:03:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/02/2024 01:30:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/22/2024 01:45:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/11/2023 01:45:18 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/17/2023 09:06:03 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/14/2023 09:05:14 PM
ZenaTech, Inc. (NASDAQ: ZENA) Launchs IQ Nano Drone for Commercial Indoor Use • HALO • Oct 10, 2024 8:09 AM
CBD Life Sciences Inc. (CBDL) Targets Alibaba as the Next Retail Giant for Wholesale Expansion of Top-Selling CBD Products • CBDL • Oct 10, 2024 8:00 AM
Foremost Lithium Announces Option Agreement with Denison on 10 Uranium Projects Spanning over 330,000 Acres in the Athabasca Basin, Saskatchewan • FAT • Oct 10, 2024 5:51 AM
Element79 Gold Corp. Reports Significant Progress in Community Relations and Development Efforts in Chachas, Peru • ELEM • Oct 9, 2024 10:30 AM
Unitronix Corp Launches Share Buyback Initiative • UTRX • Oct 9, 2024 9:10 AM
BASANITE INDUSTRIES, LLC RECEIVES U.S. PATENT FOR ITS BASAFLEX™ BASALT FIBER COMPOSITE REBAR AND METHOD OF MANUFACTURING • BASA • Oct 9, 2024 7:30 AM